ACTA2 |
actin alpha 2 |
AGEs |
advanced glycation end products |
Bfgf |
basic fibroblast growth factor |
CAT |
catalase |
CCL |
C-C motif chemokine ligand |
CX3CL |
C-X3-C motif chemokine ligand |
CXCL |
C-X-C motif chemokine ligand |
CXCR |
C-X-C motif chemokine receptor |
DLK1 |
delta-like noncanonical Notch ligand 1 |
DPP4 |
dipeptidyl peptidase-4 |
ECM |
extracellular matrix |
EMT |
epithelial-mesenchymal transition |
G-CSF |
granulocyte colony-stimulating factor |
GM-CSF |
granulocyte/macrophage colony-stimulating factor |
GPx |
glutathione peroxidase |
HDFs |
human dermal fibroblasts |
HO-1 |
heme oxygenase-1 |
IDH2 |
isocitrate dehydrogenase (NADP(+)) |
IGF1 |
insulin like growth factor 1 |
IKK |
inhibitory kappa kinase |
IL |
interleukin |
INF γ |
interferon |
ITGA1 |
integrin subunit alpha 1 |
Keap1 |
Kelch-like ECH associated protein 1 |
LPO |
lipid peroxidation |
MAF |
musculoaponeurotic fibrosarcoma |
MAPKs |
mitogen-activated protein kinases |
MET |
mesenchymal-epithelial transition |
MMPs |
matrix metalloproteinases |
NF-kB |
nuclear factor kappa-light-chain-enhancer of activated B cells |
NLRP3 |
NLR family pyrin domain containing 3 |
NQO1 |
NAD(P)H:quinone oxidoreductase 1 |
Nrf2 |
nuclear factors (erythroid-derived 2), factor 2 |
PDGFR-α |
platelet derived growth factor receptor alpha |
PI3K |
phosphatidylinositol-3-OH kinase |
PTEN |
reduced phosphatase and tensin homologs |
SCA1 |
spinocerebellar ataxia type 1 |
SOD |
superoxide dismutase |
TGF-β |
transforming growth factor |
TIMPs |
tissue inhibitors of metalloproteinase |
TLR |
toll-like receptors |
TNF-α |
tumor necrosis factor |